furosemide · Scpharmaceuticals · NDA 209988
Furoscix Readyflow (Autoinjector)
Earliest generic entry, as listed
30 Jan 2040
Blocked by patent: US 11497755, US 11559535, US 11571434, US 11998555, US 12048709, US 12491193, US 12491194, US 12491195, US 12491196, US 12491197.
Listed patents · 10 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11497755 | product | 30 Jan 2040 |
| US 11559535 | product | 30 Jan 2040 |
| US 11571434 | product | 30 Jan 2040 |
| US 11998555 | product, use U-4589 | 30 Jan 2040 |
| US 12048709 | product, use U-4588 | 30 Jan 2040 |
| US 12491193 | product, use U-4588 | 30 Jan 2040 |
| US 12491194 | product, use U-4588 | 30 Jan 2040 |
| US 12491195 | product, use U-4588 | 30 Jan 2040 |
| US 12491196 | product, use U-4588 | 30 Jan 2040 |
| US 12491197 | product, use U-4588 | 30 Jan 2040 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 209988 · 002 · RLD | solution, subcutaneous | 80MG/ML (80MG/ML) | 30 Jan 2040 |